FOLLOW US
The healthcare & pharma category is going through a time of transformation, due to continued economic uncertainty, evolving consumer dynamics, and a heightened focus on health and wellness. Consumers and brands alike are increasingly focused on healthcare accessibility, from expansion of services to treatment affordability, especially when it comes to mental health.
Facing increased competition and volatile consumer perception, the Healthcare & Pharma category will continue to be more innovative and nimble to creative consumer connections and keep pace with evolving consumer behaviors.
For more information, please contact Megan Ryan.
56% of the blockbuster drug launches slated for 2021-2025 are expected to come from 1st time launchers
22 of the 39 blockbuster drug launches due to take place between 2021-2025 are expected to come from first-time launchers (56%, vs. just 20% between 2016-2020)
2/3 of consumers are taking at least one step to address their mental health
Source:
McKinsey, February 2021
NBCU Consumer Insights Lab, HiU: Health Is Universal Study Q1 2022
